Immune Responses After COVID-19 Vaccination in Kidney Transplant Recipients and Patients on Dialysis

• A large majority of patients with kidney failure on dialysis—but not kidney transplant recipients—developed antibody responses to SARS-CoV-2 after COVID-19 vaccination.
• Vaccination also led to strong T cell responses against the virus that causes COVID-19 in all patients on dialysis, and in nearly 58% of kidney transplant recipients.

Covid-19 vaccines also protect unvaccinated family members

Researchers at the Helsinki Graduate School of Economics have found that the Pfizer-BioNTech and Moderna Covid-19 vaccines protect both vaccinated individuals and their unvaccinated adult household members against SARS-CoV-2 infections. The study, not yet peer-reviewed, used Finnish administrative datasets to examine the link between mRNA-based Covid-19 vaccines and infection risk among vaccinated individuals as well as their unvaccinated family members.

Most New Jerseyans Support Fully Reopening Public Schools in Fall, Requiring Vaccinations for Healthcare Workers, Rutgers Poll Shows

As vaccination rates increase and prospects of normal life return more than a year into the coronavirus pandemic, New Jerseyans differ on various aspects of this “new normal” and how comfortable they feel, according to the latest Rutgers-Eagleton Poll.

Perlmutter Cancer Center at NYU Langone Health Joins Call for Urgent Action to Get Cancer-Preventing HPV Vaccination Back on Track

Perlmutter Cancer Center at NYU Langone Health is collaborating with more than 70 other National Cancer Institute (NCI)-designated cancer centers and partner organizations to issue a joint statement urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.

Rutgers Pediatric Infectious Disease Expert Available to Discuss Pfizer’s Vaccine Approved by FDA for Children

Pediatric infectious disease expert David Cennimo is available to discuss the Food and Drug Administration approving Pfizer’s COVID-19 vaccine for emergency use on kids ages 12 to 15. “The Pfizer vaccine had a great track record of safety and success since…

Story Tips from Johns Hopkins Experts on COVID-19

How Can Scientists Predict a COVID-19 Outbreak? There’s an App for that; Johns Hopkins Medicine Collaborates with the City and Faith Organizations to Offer Guidance on Safely Reopening Houses of Worship; Johns Hopkins Hospital Patient ‘Grateful to Still Be Alive’ After Two-Month Hospitalization with COVID-19; “12 Things You Need To Know” Infographic…

Story Tips from Johns Hopkins Experts on COVID-19

NEWS STORIES IN THIS ISSUE:

PREGNANT AFTER THE FIRST DOSE OF COVID-19 VACCINE — NOW WHAT?
STUDY SHOWS VACCINES MAY PROTECT AGAINST NEW COVID-19 STRAINS … AND MAYBE THE COMMON COLD
EXPANDED DASHBOARD TOOL RANKS ACCESSIBILITY OF STATE VACCINE WEBSITES

How do you plan a mass vaccination clinic? Iowa State students are working on it.

Iowa State’s COVID-19 vaccination plan ramps up starting April 20 as all adult students qualify and a mass vaccination clinic takes over State Gym’s three basketball courts. But it’s not as simple as setting up booths and having vaccines ready. That’s where industrial engineering students come in.

UCI announces employee, student back-to-campus plans

Irvine, Calif., April 20, 2021 — Taking what it has learned from remote work and learning practices over the past 15 months, the University of California, Irvine will begin instituting back-to-campus plans for employees and students that will include hybrid workplaces and flexible coursework. The transition back to campus will be managed in phases starting July 1, with the university being fully operational in person by Sept.

Rutgers Expert Addresses Questions on COVID-19 Vaccine Rollout and Variant Issues

Stanley H. Weiss, an epidemiologist in infectious and chronic diseases, and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, talks about vaccine side effects, the hesitancy that still exists and why it is important to get vaccinated when it’s your turn.

Real-World Data At UT Southwestern Shows Benefit of Early Vaccination on Health Care Workforce

DALLAS – March 23, 2021 – Vaccinating health care workers resulted in an immediate and notable reduction of positive COVID-19 cases among employees, reducing the number of required isolations and quarantines by more than 90 percent, according to data at UT Southwestern Medical Center published in the New England Journal of Medicine.

Rutgers University’s Resilient, Innovative Year Confronting COVID-19

The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.

An epidemiologist breaks down the numbers on Johnson & Johnson’s single-dose vaccine

While the Johnson & Johnson single-dose COVID-19 vaccine that has now received emergency use authorization by the U.S. Food and Drug Administration has a lower efficacy rate compared to other previously approved vaccines, an expert with The University of Texas Health Science Center at Houston (UTHealth) explains why it is still a significant step toward ending the COVID-19 pandemic.

University of Northern Colorado Associate Professor Nick Pullen Provides Expertise on COVID-19 Vaccinations

Nick Pullen, Ph.D., an associate professor of Biological Sciences at the University of Northern Colorado (UNC), provides expertise regarding the topic of COVID-19 vaccinations and immunity.  Pullen’s research centers around the body’s immune response, specifically chronic inflammation, asthma and allergies.…

Autoimmune Newscast: Should I Get the COVID-19 Vaccine?

The approval of COVID-19 vaccines has brought with it hope, excitement, as well as concerns. AARDA is committed to ensuring you have the information you need to make the right decisions for your health. A panel of medical experts will discuss frequently asked questions regarding COVID-19 vaccines, as well as address audience questions during our upcoming Autoimmune Newscast, “Should I Get the COVID-19 Vaccine?” on 2/26 at 2pm ET

Cancer Organizations Urge Priority Access to COVID-19 Vaccine for Cancer Patients, Survivors

130 cancer centers and other cancer organizations sent a letter to President Joseph R. Biden, key members of his administration, and leading state public health officials to strongly encourage prioritizing patients with cancer and survivors of cancer when administering lifesaving COVID-19 vaccines.

GLOBAL POLIOVIRUS RISK MANAGEMENT AND MODELING

Launched in 1988, the Global Polio Eradication Initiative (GPEI) stands out as one of the largest, internationally coordinated global public health major projects conducted to date, with cumulative spending of over $16.5 billion for 1988–2018, according to the World Health Organization (WHO). More than 30 years later, stubborn outbreaks of wild poliovirus still occur in Afghanistan and Pakistan, where cases have been increasing since 2018. The global eradication of polio continues to be an elusive goal.

AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health

AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.

AACI Applauds Approval of COVID-19 Vaccine, Supports Widespread Vaccination Efforts

The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.

Early Access to COVID-19 Vaccination Essential for Anesthesia Professionals, ASA Says

With the first round of COVID-19 vaccines being deployed to states across the country, the American Society of Anesthesiologists (ASA) advises that anesthesia professionals, and other frontline health care workers, be prioritized to receive early access to the COVID-19 vaccination given their high risk of exposure to the virus in operating rooms, labor and delivery suites, procedural areas, emergency rooms and critical care units.

UNLV Immunologist on the Differences Between Two Leading COVID-19 Vaccine Candidates

Millions around the world have waited for news about a COVID-19 vaccine, regarding it as the beginning of the end for the global pandemic and a herald for the eventual return to “normal life.” Recent announcements from pharmaceutical companies Pfizer and Moderna that their respective late-stage vaccine trials have shown a 90% or better effectiveness rate have received international applause, excitement furthered with estimates that doses could be ready as early as December.

Smiling sincerely or grimacing can significantly reduce the pain of needle injection

Irvine, Calif., Dec. 1, 2020 — The coming of winter means cooler temperatures, shorter days and flu shots. While no one looks forward to a vaccination, a study led by the University of California, Irvine, has found that either a sincere smile or a grimace can reduce the pain of a needle injection by as much as 40 percent. A genuine, or Duchenne, smile – one that elevates the corners of the mouth and creates crow’s feet around the eyes – can also significantly blunt the stressful, needle-related physiological response by lowering the heart rate.

Rutgers Vaccine Expert Available to Discuss Moderna’s FDA Submission

Rutgers’ principal investigator for the Moderna phase 3 coronavirus vaccine clinical trial at Rutgers New Jersey Medical School is available to discuss the drugmaker’s submission of its vaccine to the U.S. Food and Drug Administration for regulatory approval. “It is…

Over half of adults over 50 say they’ll get vaccinated against COVID-19, but many will want to wait, poll finds

A new poll of adults ages 50 to 80 suggests that achieving the widespread vaccination against COVID-19 needed to protect this high-risk group and end the pandemic will be an uphill climb, and require clear, transparent communication from health providers and others.

Rutgers Expert Available to Discuss Communicating About COVID-19 Vaccine

New Brunswick, N.J. (Sept. 17, 2020) – Rutgers University–New Brunswick Professor William Hallman is available for interviews on how to communicate with the public about a potential COVID-19 vaccine. “For a COVID-19 vaccine to be embraced by the public, officials can’t…

Athletes Should be Vaccinated Against Influenza

Athletes often fear undue side effects or a training-induced deficient immune response to vaccination – in particular when vaccination is carried out during ongoing training/competition. However, influenza is a virus disease which can lead to large health problems and interfere…